Farha Fatima
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Farha Fatima has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Mohammad Zubair
Department of Medical Microbiology, Faculty of Medicine, University of Tabuk, Tabuk 71491, Saudi Arabia
2 shared publications - Muhammad Ahmed Mesaik
Department of Medical Microbiology, Faculty of Medicine, University of Tabuk, Tabuk 71491, Saudi Arabia
2 shared publications - Kashif Abbas
Department of Zoology, Faculty of Life Sciences, Aligarh Muslim University, Aligarh 202001, India
1 shared publication - Khalid Alhazmi
Department of Pathology University of Tabuk Tabuk Saudi Arabia
1 shared publication Mohd Majid Jamali
1 shared publication- Mohd Mustafa
Department of Biochemistry JN Medical College Aligarh Muslim University Aligarh India
1 shared publication
Latest Publications
- 28 October 2025
- Published by Wiley in ChemistrySelect
- Vol. 10 (41)
Antimicrobial and Antibiofilm Activity of Biogenic MgO Nanoparticles and Extract from Hibiscus sabdariffa Against Multidrug Resistance
Diabetic foot ulcers (DFUs) often involve multidrug‐resistant (MDR) infections, complicating treatment. Plant extracts and green‐synthesized nanoparticles are promising alternatives for combating these pathogens. This study aimed to evaluate the antimicrobial and antibiofilm effects of Hibiscus sabdariffa extracts and magnesium oxide nanoparticles (MgO‐GNPs) against MDR bacteria isolated from DFUs, while exploring their mechanisms through in silico analysis. Qualitative phytochemical analysis was performed on Hibiscus extracts. The MgO‐NPs were characterized using Fourier transform infrared spectroscopy (FTIR), X‐ray diffraction (XRD), ultraviolet–visible spectroscopy (UV–vis), energy dispersive X‐ray analysis (EDX), and scanning electron microscope (SEM). Their antimicrobial effects by MIC against E. coli , P. aeruginosa , and S. aureus . Biofilm inhibition and disruption were assessed in mono‐ and mixed‐species cultures. Molecular docking and molecular dynamics simulations explored interactions between MgO‐GNPs and bacterial enzymes. MgO‐GNPs demonstrated superior antimicrobial activity, with MICs between 22 and 36 µg/mL. They significantly inhibited biofilm formation and disrupted existing biofilms more effectively than Hibiscus extracts. MgO‐GNPs increased ROS levels, damaged bacterial membranes, and suppressed exopolysaccharide and alginate production. In silico studies showed strong binding affinity of MgO‐GNPs to bacterial glycosyltransferases, supporting their mechanism of action. MgO‐GNPs show promising antimicrobial and antibiofilm activity against MDR pathogens. Their ability to target biofilms and bacterial mechanisms suggests they could serve as effective alternatives for managing drug‐resistant DFU infections.
- 28 October 2025
- Published by Wiley in ChemistrySelect
- Vol. 10 (41)
Antimicrobial and Antibiofilm Activity of Biogenic MgO Nanoparticles and Extract from Hibiscus sabdariffa Against Multidrug Resistance
Diabetic foot ulcers (DFUs) often involve multidrug‐resistant (MDR) infections, complicating treatment. Plant extracts and green‐synthesized nanoparticles are promising alternatives for combating these pathogens. This study aimed to evaluate the antimicrobial and antibiofilm effects of Hibiscus sabdariffa extracts and magnesium oxide nanoparticles (MgO‐GNPs) against MDR bacteria isolated from DFUs, while exploring their mechanisms through in silico analysis. Qualitative phytochemical analysis was performed on Hibiscus extracts. The MgO‐NPs were characterized using Fourier transform infrared spectroscopy (FTIR), X‐ray diffraction (XRD), ultraviolet–visible spectroscopy (UV–vis), energy dispersive X‐ray analysis (EDX), and scanning electron microscope (SEM). Their antimicrobial effects by MIC against E. coli , P. aeruginosa , and S. aureus . Biofilm inhibition and disruption were assessed in mono‐ and mixed‐species cultures. Molecular docking and molecular dynamics simulations explored interactions between MgO‐GNPs and bacterial enzymes. MgO‐GNPs demonstrated superior antimicrobial activity, with MICs between 22 and 36 µg/mL. They significantly inhibited biofilm formation and disrupted existing biofilms more effectively than Hibiscus extracts. MgO‐GNPs increased ROS levels, damaged bacterial membranes, and suppressed exopolysaccharide and alginate production. In silico studies showed strong binding affinity of MgO‐GNPs to bacterial glycosyltransferases, supporting their mechanism of action. MgO‐GNPs show promising antimicrobial and antibiofilm activity against MDR pathogens. Their ability to target biofilms and bacterial mechanisms suggests they could serve as effective alternatives for managing drug‐resistant DFU infections.
- Open Access
- 2 December 2024
- Published by MDPI AG in Microbiology Research
- Vol. 15 (4) , 2535-2553
Disruption of Biofilm Formation by Dead Sea Soil Extracts: A Novel Approach Against Diabetic Foot Wound Isolates
Bacterial biofilms are closely associated with the rising threat of antimicrobial resistance, which is becoming a global concern. Recently, there has been increased interest in natural extracts as potential antimicrobial agents. One such extract is Dead Sea mud. While there is some evidence of its antimicrobial properties, it has not been extensively studied. Therefore, we designed a study to evaluate the potential of Dead Sea soil as an antimicrobial agent. For this purpose, three bacterial species (Pseudomonas aeruginosa, Escherichia coli, and Staphylococcus aureus) were isolated from the ulcerated foot of a patient in a hospital in Tabuk. P. aeruginosa exhibited significant antibiotic resistance, particularly to Levofloxacin (90%) and Tobramycin (80%), while S. aureus showed 70% resistance to Levofloxacin but no vancomycin resistance. Biofilm activity varied among bacterial strains, with P. aeruginosa showing 30% strong biofilm production. MIC values indicated resistance levels, with P. aeruginosa strain PA8 having the highest MIC at 650 µL/mL. All strains showed significant differences in exopolysaccharide (EPS) production at 0.25 × MIC (p ≤ 0.05) and 0.5 × MIC (p ≤ 0.005). Similarly, alginate production was significantly reduced at 0.25 × MIC (p ≤ 0.05), with even greater inhibition at 0.5 × MIC for combinations such as EC7 + SA5 (p ≤ 0.001). Hydrophobicity significantly changed at 0.25 × MIC (p ≤ 0.05), and combinations revealed highly significant reductions at 0.5 × MIC (p ≤ 0.001). Additionally, significant differences in outer membrane disruption were observed (p ≤ 0.05) with greater effects at 0.5 × MIC (p ≤ 0.005). Swarming motility was notably reduced for SA5 at 0.25 × MIC (p ≤ 0.05) and for PA2 at 0.5 × MIC (p ≤ 0.001). Chitinase activity showed greater reductions at 0.5 × MIC, with EC7 exhibiting the highest decrease. Lastly, sub-MIC concentrations enhanced reactive oxygen species (ROS) production, particularly for strains PA2 and SA5. Our results demonstrate the excellent potential of Dead Sea soil extract as an antimicrobial compound. Future studies should incorporate in vivo models to validate these findings clinically.
- 2 December 2024
- Published by MDPI AG in Microbiology Research
- Vol. 15 (4) , 2535-2553
Open AccessDisruption of Biofilm Formation by Dead Sea Soil Extracts: A Novel Approach Against Diabetic Foot Wound Isolates
Bacterial biofilms are closely associated with the rising threat of antimicrobial resistance, which is becoming a global concern. Recently, there has been increased interest in natural extracts as potential antimicrobial agents. One such extract is Dead Sea mud. While there is some evidence of its antimicrobial properties, it has not been extensively studied. Therefore, we designed a study to evaluate the potential of Dead Sea soil as an antimicrobial agent. For this purpose, three bacterial species (Pseudomonas aeruginosa, Escherichia coli, and Staphylococcus aureus) were isolated from the ulcerated foot of a patient in a hospital in Tabuk. P. aeruginosa exhibited significant antibiotic resistance, particularly to Levofloxacin (90%) and Tobramycin (80%), while S. aureus showed 70% resistance to Levofloxacin but no vancomycin resistance. Biofilm activity varied among bacterial strains, with P. aeruginosa showing 30% strong biofilm production. MIC values indicated resistance levels, with P. aeruginosa strain PA8 having the highest MIC at 650 µL/mL. All strains showed significant differences in exopolysaccharide (EPS) production at 0.25 × MIC (p ≤ 0.05) and 0.5 × MIC (p ≤ 0.005). Similarly, alginate production was significantly reduced at 0.25 × MIC (p ≤ 0.05), with even greater inhibition at 0.5 × MIC for combinations such as EC7 + SA5 (p ≤ 0.001). Hydrophobicity significantly changed at 0.25 × MIC (p ≤ 0.05), and combinations revealed highly significant reductions at 0.5 × MIC (p ≤ 0.001). Additionally, significant differences in outer membrane disruption were observed (p ≤ 0.05) with greater effects at 0.5 × MIC (p ≤ 0.005). Swarming motility was notably reduced for SA5 at 0.25 × MIC (p ≤ 0.05) and for PA2 at 0.5 × MIC (p ≤ 0.001). Chitinase activity showed greater reductions at 0.5 × MIC, with EC7 exhibiting the highest decrease. Lastly, sub-MIC concentrations enhanced reactive oxygen species (ROS) production, particularly for strains PA2 and SA5. Our results demonstrate the excellent potential of Dead Sea soil extract as an antimicrobial compound. Future studies should incorporate in vivo models to validate these findings clinically.
- 4 May 2022
- Published by Magnolia Press in Zootaxa
- Vol. 5133 (2) , 247-269
Revision of Indian species of Caenohomalopoda Tachikawa (Hymenoptera: Encyrtidae)
The Indian species of the genus Caenohomalopoda Tachikawa (Hymenoptera: Encyrtidae) are revised. The seven species known from India are redescribed, and a new species, C. sudhiri sp. nov., is described. An identification key to the eight Indian species is given.
- 4 May 2022
- Published by Magnolia Press in Zootaxa
- Vol. 5133 (2) , 247-269
Revision of Indian species of Caenohomalopoda Tachikawa (Hymenoptera: Encyrtidae)
The Indian species of the genus Caenohomalopoda Tachikawa (Hymenoptera: Encyrtidae) are revised. The seven species known from India are redescribed, and a new species, C. sudhiri sp. nov., is described. An identification key to the eight Indian species is given.
- 19 May 2017
- Published by Taylor & Francis in Oriental Insects
- Vol. 51 (4) , 397-408
Description of two new species of Anagyrini (Hymenoptera: Encyrtidae), with some records from India
- 19 May 2017
- Published by Taylor & Francis in Oriental Insects
- Vol. 51 (4) , 397-408
Description of two new species of Anagyrini (Hymenoptera: Encyrtidae), with some records from India